… response in the neoadjuvant setting highlights the importance of pathology in response …
adequate sampling and reproducible response scoring. To date, few systems of pathologic …

… The immunologic effects of the PD-1 pathway on T cell priming, effector function, and
exhaustion suggest distinct mechanisms underlying neoadjuvant immunotherapy versus …

… Since the development of neoadjuvant immunotherapy for … the feasibility of neoadjuvant
immunotherapy in MPLC. Here, … neoadjuvant pembrolizumab, and showing mixed response. …

… the cellular mechanisms that occur during successful neoadjuvant immunotherapy and
highlights … Here we also discuss strategies required for successful neoadjuvant immunotherapy, …

… setting and its potential mechanism of action. We will also highlight the potential caveats
of neoadjuvant immunotherapy and the questions that remain to be answered using this …

… remain an important tool to study underlying mechanisms of treatment resistance and can …
of responses to immunotherapies in cancer, the members reviewed the underlying mechanism …

… possibly supporting the hypothesized immunologic mechanisms underpinning neoadjuvant
ICB and validating pathologic response as an early surrogate endpoint for long-term clinical …

… neoadjuvant immunotherapy is a promising therapeutic strategy for resectable NSCLC patients,
with long-term response … pathologic response of neoadjuvant immunotherapy ranged up …

… for understanding immune mechanisms behind failure and … as predictive tools for treatment
response. Furthermore, CD95 … and melanoma response to neoadjuvant immune checkpoint …

… Neoadjuvant Immunotherapy Working Group, this article summarizes the current state of
neoadjuvant immunotherapy … recommendations related to future neoadjuvant trial designs and …